Boldenone 200mg/ml 10x1ml Ampullen by Pharma Group

Usage

1. Confirm your bulking-cycle goals and establish a pre-cycle blood panel (haematocrit, lipid profile, serum testosterone, liver enzymes) to set your personal safety baselines before the first injection.
2. Draw the ampoule contents using an 18–21G drawing needle into a sterile syringe; snap the ampoule neck cleanly and inspect the oil for visible particulates before transferring to an injection needle.
3. Administer intramuscularly — gluteus maximus or vastus lateralis are preferred sites for the oil volume — using a 23–25G, 1–1.5 inch injection needle; rotate sites across the bulking cycle to avoid localised tissue fibrosis.
4. Split the total weekly bulking dose across two injections (e.g. Monday and Thursday) to maintain consistent plasma levels; at 200mg/ml, a 400mg weekly dose divides cleanly into two 1.0ml draws.
5. Stack testosterone enanthate alongside boldenone as the androgenic support compound throughout the bulk; adjust the testosterone-to-boldenone ratio based on how estrogenic response and libido track across weeks.
6. Schedule repeat blood panels at weeks 6 and 12 of the bulking block; use haematocrit, lipid, and hormonal data to decide whether to hold, escalate, or reduce the weekly dose before completing the cycle.

Warnings

Frequently asked questions

Is boldenone undecylenate an effective compound for an off-season bulking cycle?

Yes — boldenone undecylenate is well-suited to off-season bulking because it drives steady lean-mass accrual through androgen-receptor-mediated nitrogen retention and satellite-cell activation without the estrogenic water weight associated with higher-aromatising androgens. The gains accumulate gradually over a 14–20 week bulk, producing a denser, drier look than comparable testosterone-only programmes.

How should weekly boldenone dosage be structured during a bulking phase?

Most bulking protocols start at 300–400mg per week for the first four to six weeks, with a blood-marker review before stepping up by 100mg increments toward a 500–600mg weekly ceiling if haematocrit and lipid values remain within acceptable ranges. At 200mg/ml, each 100mg increment equals exactly 0.5ml, making dose progression during the bulk precise and straightforward to track.

What compounds pair well with boldenone undecylenate in a lean-bulk stack?

Testosterone enanthate or testosterone cypionate at 400–600mg weekly is the standard backbone alongside boldenone in a bulk, providing full androgenic support. Athletes seeking additional anabolic drive in later bulking weeks sometimes introduce nandrolone decanoate; boldenone carries negligible progesterone-receptor affinity compared to nandrolone, so the stack's progestogenic burden remains lower than a testosterone-plus-nandrolone pairing at equivalent doses.

What is the advantage of 10x1ml single-dose ampoules over a multi-dose vial for a bulking cycle?

Single-dose ampoules eliminate the repeated-puncture contamination risk inherent in multi-dose vials — a meaningful benefit across the 14–20 week duration typical of a bulking cycle, where cumulative injection count is high. Each ampoule is glass-fusion sealed in a GMP cleanroom, so the sterility of dose number fifteen is identical to dose number one, with no stopper degradation or septum coring introducing particulates.

Why is 200mg/ml the lowest concentration in the boldenone range, and does that matter for bulking?

At 200mg/ml, Pharma Group's presentation allows the smallest measurable dose adjustment — 0.5ml per 100mg — giving athletes entering a first bulking cycle maximum flexibility to dial in volume without committing to the larger per-injection draws required by 300–500mg/ml formulations. For conservative dose escalation during a bulk, finer volumetric resolution directly reduces the risk of overshooting haematocrit or androgenic load targets. (2) angle_used

Manufacturer

Pharma Group entered the pharmaceutical-grade injectable market with a stated focus on precision filling technology and documented batch traceability — both particularly relevant for an injectable boldenone product consumed across a 14–20 week bulking cycle where batch-to-batch consistency directly affects progressive dose planning. The brand's quality architecture centres on three pillars: GMP-classified cleanroom production, HPLC-confirmed active-ingredient concentration, and LAL endotoxin clearance for every released batch. Pharma Group packages its boldenone line in the 10×1ml single-dose ampoule format from the outset — a deliberate presentation choice aligned with sterility requirements of long-duration bulking cycles rather than an afterthought addition to an existing vial-based lineup. This origin story distinguishes Pharma Group from contract-fill operations that retrofit multi-dose vials into ampoule packaging; the cleanroom infrastructure and glass-fusion sealing process were integrated into the brand's production model at foundation.